Xue Y - Search Results

1

Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.

Xue Y, Gao S, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X, Wu R. Xue Y, et al. Expert Opin Drug Deliv. 2021 Feb;18(2):187-203. doi: 10.1080/17425247.2021.1825376. Epub 2020 Oct 5. Expert Opin Drug Deliv. 2021. PMID: 32954856 Review.

2

A comprehensive review on contact lens for ophthalmic drug delivery.

Xu J, Xue Y, Hu G, Lin T, Gou J, Yin T, He H, Zhang Y, Tang X. Xu J, et al. Among authors: xue y. J Control Release. 2018 Jul 10;281:97-118. doi: 10.1016/j.jconrel.2018.05.020. Epub 2018 May 18. J Control Release. 2018. PMID: 29782944 Review.

3

Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.

Chen Q, Luo L, Xue Y, Han J, Liu Y, Zhang Y, Yin T, Wang L, Cun D, Gou J, He H, Tang X. Chen Q, et al. Among authors: xue y. Acta Biomater. 2019 Jul 1;92:205-218. doi: 10.1016/j.actbio.2019.05.007. Epub 2019 May 6. Acta Biomater. 2019. PMID: 31071475

4

Thermodynamic stability of cisplatin-loaded polymeric micelles and the phenotypic switching of the tumor-associated macrophages induced by combination of cisplatin-loaded micelles and Anti-PD-L1 antibody.

Yuan H, Xue Y, Guo C, Song J, Zhang Y, Yin T, He H, Gou J, Tang X. Yuan H, et al. Among authors: xue y. Int J Pharm. 2022 Jun 25;622:121860. doi: 10.1016/j.ijpharm.2022.121860. Epub 2022 May 30. Int J Pharm. 2022. PMID: 35654378

5

P4HA1: an important target for treating fibrosis related diseases and cancer.

Yang X, Zhang D, Li M, Shao Y, Zhang X, Xue Y. Yang X, et al. Among authors: xue y. Front Pharmacol. 2024 Nov 6;15:1493420. doi: 10.3389/fphar.2024.1493420. eCollection 2024. Front Pharmacol. 2024. PMID: 39568592 Free PMC article. Review.

6

Agricultural ecosystems rather than fertilization strategies drives structure and composition of the ureolytic microbial functional guilds.

Lv N, Gong P, Sun H, Sun X, Liu Z, Xie X, Xue Y, Song Y, Wu K, Wang T, Wu Z, Zhang L. Lv N, et al. Among authors: xue y. J Environ Manage. 2024 Nov 19;372:123148. doi: 10.1016/j.jenvman.2024.123148. Online ahead of print. J Environ Manage. 2024. PMID: 39566206

7

Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance.

Mei T, Ye T, Huang D, Xie Y, Xue Y, Zhou D, Wang W, Chen J. Mei T, et al. Among authors: xue y. Cell Oncol (Dordr). 2024 Nov 20. doi: 10.1007/s13402-024-01009-6. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 39565509 Review.

8

Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source.

Zhu W, Chen M, Zhang X, Su J, Zhang X, Nong Y, Wang B, Guo W, Xue Y, Wang D, Liao Y, Niu J, Hong Y, Drlica K, Zhao X. Zhu W, et al. Among authors: xue y. mSphere. 2024 Nov 20:e0077224. doi: 10.1128/msphere.00772-24. Online ahead of print. mSphere. 2024. PMID: 39565127

9

An empirical model of soft bellows actuator.

Qiu Z, Zhang S, Xue Y, Zhang Y, Mori Y, Hirai S, Kawamura S, Wang Z. Qiu Z, et al. Among authors: xue y. Sci Rep. 2024 Nov 19;14(1):28681. doi: 10.1038/s41598-024-79084-w. Sci Rep. 2024. PMID: 39562794 Free PMC article.

10

Complete pathological response in a patient with locally advanced rectal cancer following conversion therapy: A case report.

Xue Y, Zhao Y, Dong B, Yang X. Xue Y, et al. Asian J Surg. 2024 Nov 18:S1015-9584(24)02381-9. doi: 10.1016/j.asjsur.2024.10.070. Online ahead of print. Asian J Surg. 2024. PMID: 39562244 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,077 results

Search Page

Filters